Stephan Jakober appointed to the Supervisory Board of MagForce AG

BERLIN, Germany, Oct. 22, 2013 (GLOBE NEWSWIRE) --

MagForce AG (Frankfurt, Xetra: MF6), a leading medical device company in the area of nanotechnology with a focus on oncology, today announced details on the change in the Company's Supervisory Board. Dr Jan zur Hausen stepped back from his membership position on September 13, 2013, due to personal reasons. The county court Berlin-Charlottenburg appointed Stephan Jakober as new Supervisory Board member. Stephan Jakober is Chief Financial Officer of Film House Germany AG, a Berlin- based production company for international and German movies, and works as consultant vor CIB Beratung AG (Zurich) in the area of Private Equity, Corporate Finance and Mergers & Acquisition. Prior to that, Stephan Jakober was responsible for investments in medium-sized enterprises for different European Private Equity Funds as Investment Director. Stephan Jakober studied Business Administration at the University of St Gallen (HSG). About MagForce AG MagForce AG is a leading medical device company in the field of nanomedicine in oncology, listed in the entry standard (MF6). The Company's proprietary, NanoTherm® therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator® are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm®, NanoPlan®, and NanoActivator® are trademarks of MagForce AG in selected countries. For more information, please visit Disclaimer This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward- looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated. Contact: Anne Hennecke MC Services AG T +49 89 210228-18 F +49 89 210228-88 M +49 151 12 555 759 Email: MagForce_Press Release_October 22, 2013: [HUG#1737230] Source:MagForce AG